Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
771.00
+22.00 (2.94%)
At close: May 13, 2025
Caliway Biopharmaceuticals Company Description
Caliway Biopharmaceuticals Co., Ltd. engages in the development of drugs for aesthetic medicine and chronic inflammation. The company was incorporated in 2012 and is based in New Taipei City, Taiwan.
Caliway Biopharmaceuticals Co., Ltd.
Country | Taiwan |
Founded | 2012 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Yufang Ling |
Contact Details
Address: No.99, Xintai 5th Road New Taipei City, 221 Taiwan | |
Phone | 886 2 2697 1355 |
Website | caliway.com.tw |
Stock Details
Ticker Symbol | 6919 |
Exchange | Taiwan Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Yufang Ling | Chief Executive Officer and Research & Development Chief |